RINVOQ is the first and only oral Janus kinase (JAK) inhibitor approved in the European Union (EU) to treat adult patients with giant cell arteritis (GCA) The approval is supported by data from ...

RINVOQ is the first and only oral Janus kinase (JAK) inhibitor approved in the European Union (EU) to treat adult patients with giant cell arteritis (GCA) The approval is supported by data from ...

RINVOQ is the first and only oral Janus kinase (JAK) inhibitor approved in the European Union (EU) to treat adult patients with giant cell arteritis (GCA ... particularly lung cancer, lymphoma, and ...

The risk of cancer goes up with age, in part because aging impedes the body's ability to detect and destroy cells with ...

The powerful potential of nanotechnologies and AI to detect oral cancer earlier and more accurately has been revealed by a ...

The powerful potential of nano technologies and AI to detect oral cancer earlier and more accurately have been revealed by a new study.

A don from the Department of Biochemistry of Covenant University (CU), Prof Solomon Rotimi, is making giant strides in breast cancer research. The academic research paper published in the ...

Recent high-profile discussions in the media have brought increased attention to human papillomavirus (HPV) and its connection to oral cancer. While celebrity revelations might generate headlines ...

Giant Food announced Tuesday the launch of a pilot program that provides customers with access to a multi-cancer early-detection blood test. The initiative is part of a partnership with lab test ...

ST. LOUIS – Nearly 50,000 new cases of oral cancer are diagnosed each year, with approximately 25% having no known risk factors. In recognition of Oral Cancer Awareness Month, Delta Dental of ...

Scientists could reshape cancer treatment by helping powerful drugs work better in the body by exploiting a surface protein called CD36 that helps pull substances into cells. This dramatically ...